Fort Washington Investment Advisors Inc Abbott Laboratories Transaction History

Fort Washington Investment Advisors Inc

  • $16 Billion
  • Q3 2024

A detailed history of Fort Washington Investment Advisors Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Fort Washington Investment Advisors Inc holds 36,337 shares of ABT stock, worth $4.18 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
36,337
Previous 36,751 1.13%
Holding current value
$4.18 Million
Previous $3.82 Million 8.49%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024
SELL
$100.07 - $118.13 $41,428 - $48,905
-414 Reduced 1.13%
36,337 $4.14 Million
Q2 2024

Jul 30, 2024
BUY
$100.73 - $112.44 $3,727 - $4,160
37 Added 0.1%
36,751 $3.82 Million
Q1 2024

May 13, 2024
SELL
$109.52 - $120.96 $106,891 - $118,056
-976 Reduced 2.59%
36,714 $4.17 Million
Q3 2023

Nov 07, 2023
SELL
$95.53 - $114.62 $92,377 - $110,837
-967 Reduced 2.5%
37,690 $3.65 Million
Q2 2023

Jul 28, 2023
SELL
$100.78 - $112.29 $15,721 - $17,517
-156 Reduced 0.4%
38,657 $4.21 Million
Q1 2023

Apr 28, 2023
SELL
$96.86 - $114.01 $13,172 - $15,505
-136 Reduced 0.35%
38,813 $3.93 Million
Q4 2022

Jan 30, 2023
BUY
$95.06 - $111.52 $296,111 - $347,384
3,115 Added 8.69%
38,949 $4.28 Million
Q3 2022

Oct 26, 2022
SELL
$96.76 - $112.03 $214,807 - $248,706
-2,220 Reduced 5.83%
35,834 $3.47 Million
Q2 2022

Aug 05, 2022
BUY
$102.07 - $123.37 $219,960 - $265,862
2,155 Added 6.0%
38,054 $4.14 Million
Q1 2022

May 03, 2022
SELL
$114.02 - $139.04 $1.66 Million - $2.03 Million
-14,573 Reduced 28.87%
35,899 $4.25 Million
Q4 2021

Feb 07, 2022
BUY
$115.53 - $141.46 $73,823 - $90,392
639 Added 1.28%
50,472 $7.1 Million
Q3 2021

Nov 09, 2021
SELL
$116.66 - $129.06 $20,298 - $22,456
-174 Reduced 0.35%
49,833 $5.89 Million
Q2 2021

Aug 09, 2021
SELL
$105.79 - $124.53 $18,301 - $21,543
-173 Reduced 0.34%
50,007 $5.8 Million
Q1 2021

May 05, 2021
SELL
$108.84 - $128.23 $799,974 - $942,490
-7,350 Reduced 12.78%
50,180 $6.01 Million
Q4 2020

Feb 03, 2021
SELL
$105.0 - $114.42 $162,435 - $177,007
-1,547 Reduced 2.62%
57,530 $6.3 Million
Q3 2020

Nov 10, 2020
BUY
$91.64 - $111.29 $59,840 - $72,672
653 Added 1.12%
59,077 $6.43 Million
Q2 2020

Jul 31, 2020
SELL
$76.57 - $98.0 $26,799 - $34,300
-350 Reduced 0.6%
58,424 $5.34 Million
Q1 2020

May 06, 2020
SELL
$62.82 - $91.86 $58,548 - $85,613
-932 Reduced 1.56%
58,774 $4.64 Million
Q4 2019

Feb 03, 2020
BUY
$78.51 - $87.4 $103,633 - $115,368
1,320 Added 2.26%
59,706 $5.19 Million
Q3 2019

Nov 08, 2019
SELL
$81.84 - $88.74 $2.58 Million - $2.8 Million
-31,568 Reduced 35.09%
58,386 $4.89 Million
Q2 2019

Aug 12, 2019
SELL
$72.88 - $85.0 $3.11 Million - $3.63 Million
-42,720 Reduced 32.2%
89,954 $7.57 Million
Q1 2019

May 10, 2019
SELL
$66.22 - $80.06 $385,863 - $466,509
-5,827 Reduced 4.21%
132,674 $10.6 Million
Q4 2018

Feb 05, 2019
SELL
$65.56 - $74.27 $2.18 Million - $2.47 Million
-33,297 Reduced 19.38%
138,501 $10 Million
Q3 2018

Nov 07, 2018
SELL
$60.81 - $73.36 $48,343 - $58,321
-795 Reduced 0.46%
171,798 $12.6 Million
Q2 2018

Jul 27, 2018
SELL
$57.57 - $63.54 $14,622 - $16,139
-254 Reduced 0.15%
172,593 $10.5 Million
Q1 2018

May 02, 2018
SELL
$56.27 - $63.62 $1.85 Million - $2.1 Million
-32,954 Reduced 16.01%
172,847 $10.4 Million
Q4 2017

Feb 12, 2018
SELL
$53.68 - $57.47 $282,893 - $302,866
-5,270 Reduced 2.5%
205,801 $11.7 Million
Q3 2017

Nov 13, 2017
SELL
$48.06 - $53.64 $851,671 - $950,554
-17,721 Reduced 7.75%
211,071 $11.3 Million
Q2 2017

Aug 10, 2017
BUY
N/A
228,792
228,792 $11.1 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Fort Washington Investment Advisors Inc Portfolio

Follow Fort Washington Investment Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Washington Investment Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Fort Washington Investment Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email